SAKAR HEALTHCARE
|
The Current P/E Ratio of SAKAR HEALTHCARE is 38.19.
Share Price | ₹339.9 | Sep 17,2025 |
Market Cap | ₹754.6 Cr | |
Earnings-TTM | ₹19.8 Cr | TTM-Consolidated Results |
Price/Earnings | 38.19x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹754.6 Cr] as on Sep 17,2025
(/) Earnings [ ₹19.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 38.19x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 38.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 27.63x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 16.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 7.77x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SAKAR HEALTHCARE | 19.76 | 38.19 | 754.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.34 | 388,752.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.66 | 160,626.0 |
CIPLA LTD | 5,406.81 | 23.29 | 125,951.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 59.91 | 119,932.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.11 | 109,414.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.64 | 106,025.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.45 | 104,130.0 |
LUPIN LTD | 3,722.18 | 24.92 | 92,773.7 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.63 | 63,670.4 |
ABBOTT INDIA LTD | 1,452.29 | 45.28 | 65,762.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.63x |
Max industry PE | 69.66x |
Median industry PE | 37.34x |
Average industry PE | 37.67x |
You may also like the below Video Courses